Fig. 1From: Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospectsUnderlying mechanisms contributing to mesenchymal stromal cell (MSC)-mediated neuroprotection and neurogenesis in chronic neurodegenerative conditions. GPCs, glial progenitor cells; NPCs, neural progenitor cells; VEGF, vascular endothelial growth factor; M2-Mɸ, M2 macrophages; Th2, T-helper 2; NO, nitric oxide; BCL2, B-cell lymphoma 2Back to article page